Review: taking Lexapro and Loratadine together


Summary

Drug interactions are reported among people who take Lexapro and Loratadine together. This review analyzes the effectiveness and drug interactions between Lexapro and Loratadine. It is created by eHealthMe based on reports of 965 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Lexapro and Loratadine >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lexapro

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. (latest outcomes from Lexapro 44,435 users)

Loratadine

Loratadine has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Loratadine 12,984 users)

On Aug, 27, 2016

965 people who take Lexapro, Loratadine are studied.


Number of reports submitted per year:

Lexapro and Loratadine drug interactions.

Drug effectiveness over time:

Lexapro:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 28.0% - (2 of 7 people)
  • 6 - 12 months: 0.0% - (0 of 6 people)
  • 1 - 2 years: 80.0% - (8 of 10 people)
  • 2 - 5 years: 37.0% - (3 of 8 people)
  • 5 - 10 years: 33.0% - (1 of 3 people)
  • 10+ years: 100.0% - (2 of 2 people)
  • not specified: 50.0% - (1 of 2 people)
Loratadine:
  • < 1 month: 0.0% - (0 of 11 people)
  • 1 - 6 months: 22.0% - (2 of 9 people)
  • 6 - 12 months: 0.0% - (0 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 5 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 20.0% - (1 of 5 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (2 of 2 people)

Drug effectiveness by gender:

Lexapro:
  • female: 54.0% - (13 of 24 people)
  • male: 22.0% - (4 of 18 people)
Loratadine:
  • female: 19.0% - (4 of 21 people)
  • male: 11.0% - (2 of 17 people)

Drug effectiveness by age:

Lexapro:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 30.0% - (3 of 10 people)
  • 30-39: 50.0% - (4 of 8 people)
  • 40-49: 36.0% - (4 of 11 people)
  • 50-59: 50.0% - (4 of 8 people)
  • 60+: 40.0% - (2 of 5 people)
Loratadine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 22.0% - (2 of 9 people)
  • 30-39: 12.0% - (1 of 8 people)
  • 40-49: 12.0% - (1 of 8 people)
  • 50-59: 12.0% - (1 of 8 people)
  • 60+: 20.0% - (1 of 5 people)

Most common drug interactions over time *:

< 1 month:
  • depression
  • nervousness
  • aggression
  • impulsive behaviour
  • restlessness
  • weight increased
  • activities of daily living impaired
  • anger
  • drug withdrawal syndrome
  • fall
1 - 6 months:
  • cholestasis
  • cytolytic hepatitis
  • cholecystitis chronic
  • discomfort
  • mental disorder
  • pain
  • depression
  • emotional distress
  • fear of death
  • gamma-glutamyltransferase increased
6 - 12 months:
  • dyspnoea
  • nausea
  • procedural pain
  • anaemia
  • chest pain
  • complications of transplanted kidney
  • confusional state
  • deep vein thrombosis
  • diarrhea
  • drug exposure during pregnancy
1 - 2 years:
  • pain - bones
  • obesity
  • blood cholesterol increased
  • blood triglycerides increased
  • depression
  • diabetes mellitus
  • diarrhoea
  • emotional distress
  • fatigue
  • gastrooesophageal reflux disease
2 - 5 years:
  • anxiety
  • emotional distress
  • loss of consciousness
  • basal cell carcinoma
  • cerebrovascular accident
  • generalised anxiety disorder
  • lacunar infarction
  • oesophageal spasm
  • palpitations
  • post procedural complication
5 - 10 years:
  • anxiety
  • acute respiratory failure
  • anaemia
  • cerebral infarction
  • chest pain
  • cognitive disorder
  • deep vein thrombosis
  • dyspnoea
  • depression
  • aerophagia
10+ years:
  • acid reflux
  • chronic pain
  • dementia due to other general medical condition
  • depression
  • diabetes mellitus aggravated
  • drowning
  • high blood pressure
  • osteoarthritis aggravated
not specified:
  • pain
  • nausea
  • depression
  • anxiety
  • dyspnoea
  • fatigue
  • diarrhoea
  • headache
  • anaemia
  • chest pain

Most common drug interactions by gender *:

female:
  • pain
  • depression
  • anxiety
  • nausea
  • dyspnoea
  • diarrhoea
  • injury
  • chest pain
  • fatigue
  • hypertension
male:
  • depression
  • pain
  • diarrhoea
  • pneumonia
  • fall
  • nausea
  • anaemia
  • asthenia
  • hypoaesthesia
  • gait disturbance

Most common drug interactions by age *:

0-1:
  • drug exposure during pregnancy
  • immature respiratory system
  • premature baby
2-9:
  • accidental death
  • activated partial thromboplastin time prolonged
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood alkaline phosphatase increased
  • blood glucose increased
  • body temperature decreased
  • cough
  • depressed level of consciousness
  • dizziness
10-19:
  • dehydration
  • diarrhoea
  • syncope
  • vomiting
  • colitis
  • headache
  • pancreatitis
  • pseudocyst
  • pyrexia
  • thrombocytopenia
20-29:
  • pain
  • anxiety
  • emotional distress
  • cholecystitis chronic
  • injury
  • cholelithiasis
  • mental disorder
  • chest pain
  • general physical health deterioration
  • pulmonary embolism
30-39:
  • pain
  • depression
  • nausea
  • cholecystitis chronic
  • dyspnoea
  • mental disorder
  • pulmonary embolism
  • diabetes mellitus
  • chest pain
  • cholelithiasis
40-49:
  • pain
  • depression
  • hypertension
  • asthenia
  • hypokalaemia
  • headache
  • type 2 diabetes mellitus
  • vomiting
  • activities of daily living impaired
  • back pain
50-59:
  • depression
  • pain
  • anxiety
  • fall
  • injury
  • nausea
  • hypoaesthesia
  • insomnia
  • neck pain
  • oedema peripheral
60+:
  • anaemia
  • diarrhoea
  • constipation
  • cardiac failure congestive
  • pain
  • nausea
  • urinary tract infection
  • dyspnoea
  • renal failure acute
  • respiratory failure

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lexapro and Loratadine?

Can you answer these questions?

More questions for: Lexapro, Loratadine

You may be interested in these reviews

More reviews for: Lexapro, Loratadine

On eHealthMe, Lexapro (escitalopram oxalate) is often used to treat depression. Loratadine (loratadine) is often used to treat hypersensitivity. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.